Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29993108 | 1.00 | KIF11 (0.41) | KIF11ALDH1A1KDM4EMEN1HPGD | |
| Biphenyl SCHEMBL27553552 | 0.85 | CETP (0.36) | KIF11ALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL260934 | 0.84 | KIF11 (0.47) | KIF11ALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL159683 | 0.78 | GPR3 (0.42) | KIF11ALDH1A1HPGDCETP | |
| SCHEMBL11229284 | 0.78 | KIF11 (0.41) | KIF11ALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL2092198 | 0.77 | KIF11 (0.43) | KIF11ALDH1A1KDM4EMEN1HPGD | |
| Hydrochloric Acid SCHEMBL27878364 | 0.77 | KIF11 (0.40) | KIF11ALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL15344308 | 0.77 | KIF11 (0.33) | KIF11ALDH1A1RIPK1 | |
| SCHEMBL678558 | 0.76 | ACHE (0.52) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL1802320 | 0.76 | CYP3A4 (0.53) | KIF11ALDH1A1ACHECYP3A4CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101034260-B | Photosensitive resin composition | DONGJIN SEMICOHEM CO LTD | 2012-07-18 | — | — | CN | claimed |
| CN-101034260-A | Photosensitive resin composition | DONGJIN SEMICHEM CO LTD (KR) | 2007-09-12 | — | — | CN | claimed |
| EP-3214497-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, PHOTO-CURABLE DRY FILM AND METHOD FOR PRODUCING THE SAME, PATTERNING PROCESS, AND LAMINATE | Shin-Etsu Chemical Co., Ltd. (JP) | 2017-09-06 | — | — | EP | disclosed |
| CN-106444288-A | Chemically amplified positive resist composition and pattern forming process | 信越化学工业株式会社 | 2017-02-22 | — | — | CN | disclosed |
| CN-103781813-B | The epoxy resin adduct mixed | 蓝立方知识产权有限责任公司 | 2016-09-14 | — | — | CN | disclosed |
| CN-105676601-A | Pretreatment method of glass substrate used for forming etching mask | 东京应化工业株式会社 | 2016-06-15 | — | — | CN | disclosed |
| CN-103228694-B | Heat curable composition and the thermosetting material prepared by heat curable composition | Blue Cube Intellectual Property Co.,Ltd. (US) | 2016-04-27 | — | — | CN | disclosed |
| CN-105404096-A | CHEMICALLY AMPLIFIED POSITIVE RESIST DRY FILM, DRY FILM LAMINATE AND METHOD OF PREPARING LAMINATE | SHINETSU CHEMICAL CO | 2016-03-16 | — | — | CN | disclosed |
| CN-103163730-B | Chemical amplification type photoetching compositions is utilized to carry out the method for minor groove patterning | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (CN) | 2016-03-09 | — | — | CN | disclosed |
| CN-105301905-A | Chemically amplified positive resist composition and patterning process | SHINETSU CHEMICAL CO | 2016-02-03 | — | — | CN | disclosed |
| CN-105283432-A | Composition comprising a compound containing a vinyl group | TOKYO OHKA KOGYO CO LTD | 2016-01-27 | — | — | CN | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| CN-101034260-A | Photosensitive resin composition | DONGJIN SEMICHEM CO LTD (KR) | 2007-09-12 | — | — | CN | disclosed |
| CN-1983031-A | Photosensitive resin composition for organic light emitting diodes | DONGJIN SEMICHEM CO LTD (KR) | 2007-06-20 | — | — | CN | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| CN-1607461-A | Resist polymer, resist composition and patterning process | SHINETSU CHEMICAL CO (JP) | 2005-04-20 | — | — | CN | disclosed |
| CN-1578794-A | Anhydrous, liquid phase process for preparing hydroxyl containing polymers of enhanced purity | DUPONT ELECTRONIC TECHNOLOGIES (US) | 2005-02-09 | — | — | CN | disclosed |
| CN-1550896-A | Processes for preparing photoresist compositions and the product | ��Ļ���Ű˾ | 2004-12-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | KIF11 3992/4885ALDH1A1 412/4885KDM4E 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.